Lorenzo Biasio
Market Intelligence Leader

About

Lorenzo Biasio has led Market Intelligence at Ypsomed since 2024. He started his career at IMS Consulting Group (now IQVIA) and spent 10 years as the Senior Global Healthcare Analyst at Credit Suisse Private Bank before joining Ypsomed.

Mr Biasio holds a master’s degree in Biology from ETH in Zurich, Switzerland, and is a CFA Charterholder.

Contributions

SUSTAINABILITY

SUSTAINABLE GLP-1 DRUG DELIVERY: FUTURE-PROOFING THERAPY ADMINISTRATION FOR OBESITY AND BEYOND

Lorenzo Biasio and Gloria Skibba discuss the integration of Ypsomed’s Net Zero Program into its self-injection platforms. With the evolution of GLP-1 therapies and the exploration of higher-dose formulations, the demand for higher-volume autoinjectors is increasing; this article explains how Ypsomed has also applied its sustainability principles to larger-volume delivery.